Zero Medicaid Rebate For Specialty Rx? Reform Law Puts CMS In Conundrum

A quirk of the health care reform law puts CMS in the position of having to figure how, or even if, it will be able to authorize the collection of Medicaid rebates on drugs not distributed via a retail pharmacy - including many cancer drugs, imaging contrast agents, and other specialty biopharma products.